Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Damon Asher
Advertisement
Damon Asher, PHD, is associate director Americas vaccine and viral therapies, MilliporeSigma.
Articles by Damon Asher
Advertisement
Latest Updated Articles
Ensuring Viral Safety of Viral Vaccines and VectorsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
